Daratumumab is a medication used to treat multiple myeloma. It works by targeting a specific protein on cancer cells, helping the immune system identify and destroy these cells.

Lenalidomide is a medication that helps fight multiple myeloma by strengthening the immune system and preventing the growth of cancer cells. It also works by blocking the blood supply to cancer cells.

Dexamethasone is a steroid medication that helps reduce inflammation and suppress the immune system. In multiple myeloma treatment, it is often used in combination with other medications to enhance their effectiveness.

Linvoseltamab is an investigational medication being studied for the treatment of multiple myeloma. It is being tested as an alternative treatment option to compare its effectiveness with the standard treatment combination.

Multiple Myeloma – A type of blood cancer that develops in plasma cells, which are white blood cells that help fight infections. In this condition, abnormal plasma cells multiply uncontrollably in the bone marrow, forming tumors in multiple bones throughout the body. These cancerous cells interfere with the production of normal blood cells and can cause bone damage, leading to weakened bones. The disease also causes the overproduction of a single type of antibody, which can damage the kidneys and other organs. Multiple myeloma typically develops gradually and can affect various parts of the body, particularly the bones of the spine, skull, pelvis, rib cage, and hips.